Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Consumer Discretionary · ·
$62.87
▲ $1.11 (+1.8%)
Market data updated: 09/17 09:17 PM
Fundamentals updated: 09/17/2026
News analyzed: 09/17/2026
Market Cap
$1.43B
Day Range
$61.35 - $63.05
52-Week Range
$41.82 - $68.00
Beta
—
Next Earnings
27.10.2026
SCL is a stock from the Consumer Cyclical sector — Retail, automotive, and leisure — demand rises and falls with economic sentiment and consumers' disposable income.
+28.6% (1Y)
Strengths: 8/33 factors positiveRisk: High
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Price vs. SMA 50
Price is above the 50-day average
Technical
Biggest negative driver
DCF Fair Value
Estimated fair value: -$6.94 vs. price $62.87 (-111.0%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
53
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
34
Quality
42
Value
38
Momentum
72
Risk
42
Sentiment
100
Fundamental
38
Institutional
No data available
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Stepan Company has primarily focused on its financial performance and strategic initiatives. The company reported a **45% year-over-year increase in Q2 EBITDA**, driven by growth in higher-margin products, cost-cutting efforts targeting **$100 million in savings**, and improved volume gains. Analysts also highlighted its **dividend sustainability** amid mixed earnings, while speculation on stock volatility from options traders was noted. Overall, the narrative centers on margin recovery and operational efficiency.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Stepan Company. News trend score: 100. Reason: 11 of the last 19 articles are positive, versus 1 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
27
🎯 Conviction (vs. Emotion)
36
Psychology
30
Fundamentals
38
Technical
72
Valuation
38
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price rise has far outpaced the actual improvement in fundamental data.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Price (3M)
+17%
Market Narrative
65
Fundamental Reality
36
Narrative Gap
+29
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests a **narrative-reality disconnect** (gap of 26) where euphoric overvaluation (+12.8% above 200-day avg.) dominates despite weak momentum (-2.3% ROC) and neutral RSI (46). The perfect news sentiment (100/100) fuels detached optimism, while FOMO (12) and panic selling (8) remain muted by low volatility (0.87x ATR). The key question: *Is the extreme overvaluation (Euphoria) justified by fundamentals, or will reality (weak momentum) eventually correct the narrative?*
Updated: 09/09/2026, 06:53 AM
What could change this?
👥 What the crowd believes
"EBITDA increased 45% year over year"
"Targets $100M in savings through cost reductions"
"Affirms dividend despite half-year loss concerns"
"Growth in higher-margin product areas"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Edgar Lawrence Smith — 62/100
🔴 Weakest match
Philip Fisher — 14/100
🗣️ Why do they disagree?
The methodologies here split sharply between those who see potential in SCL’s near-term positioning and those that warn of deeper structural or market risks. Samuel Armstrong Nelson’s high score suggests the stock may be oversold and ripe for a cyclical rebound, aligning with a contrarian or momentum-based view. Meanwhile, Charles Mackay and Edgar Lawrence Smith detect early crowd excitement and reasonable—but not compelling—long-term prospects, hinting at a speculative edge. However, the majority of frameworks—from Graham’s defensive criteria to Fisher’s quality focus—reject the stock outright, citing either valuation, trend resistance, or lack of growth justification. Even the more flexible Enterprising Investor standard (Graham) and Howard Marks’ market-cycle lens flag caution, implying the stock’s appeal is either overpriced or late in its cycle. The divide underscores a tension between tactical timing (Nelson, Mackay) and fundamental skepticism (Graham, Fisher), with no clear consensus beyond a handful of methodologies.
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 63
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 62
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 53
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 48
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 44
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 43
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 41
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 39
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 37
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 37
Looks late-cycle — the position Marks would treat with extra caution
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🔴 31
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 28
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🔴 27
Cycle looks stretched toward overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🔴 26
Doesn't clear Lynch's growth-at-a-reasonable-price bar
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 23
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 14
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🟢 Most indicators support an uptrend (8 bullish · 2 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Low confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
11.6%
Operating Margin
3.4%
Net Margin
2.0%
EBITDA Margin
8.8%
ROE
3.8%
ROA
2.0%
ROIC
—
EPS
$2.05
Cash
$132.69M
Total Debt
$626.71M
Current Ratio
1.29
Debt/Equity
0.50
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 1.9.2026 | $0.395 |
| 1.6.2026 | $0.395 |
| 31.5.2026 | $0.395 |
| 2.3.2026 | $0.395 |
| 1.3.2026 | $0.395 |
| 28.11.2025 | $0.395 |
| 27.11.2025 | $0.395 |
| 29.8.2025 | $0.385 |
| 28.8.2025 | $0.385 |
| 30.5.2025 | $0.385 |
| 29.5.2025 | $0.385 |
| 3.3.2025 | $0.385 |
How is Fair Value calculated? →
Current Price
$62.87
Estimated Fair Value (DCF)
-$6.94
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-111.0%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
-5.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | -5.0% | $24.10M | $22.11M |
| 2 | -3.1% | $23.35M | $19.65M |
| 3 | -1.2% | $23.05M | $17.80M |
| 4 | 0.6% | $23.20M | $16.43M |
| 5 | 2.5% | $23.78M | $15.45M |
Base FCF (last actual year)
$25.37M
Terminal Value
$374.97M
Present Value of Terminal Value
$243.71M
Enterprise Value
$335.16M
Net Debt
$494.02M
Equity Value
$-158.86M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$54.35
Tangible Book Value per Share (Tangible NAV)
$48.58
Sentiment based on basic keywords (not AI) — 11 positive, 7 neutral, 1 negative out of the last 19 articles.
SeekingAlpha · 11.9.2026
SeekingAlpha · 28.8.2026
Yahoo · 28.8.2026
MarketBeat · 28.8.2026
Zacks · 12.8.2026
SeekingAlpha · 12.8.2026
Motley Fool · 8.8.2026
Simply Wall St. · 7.8.2026
Simply Wall St. · 31.7.2026
MarketBeat · 30.7.2026
Moby · 30.7.2026
GuruFocus.com · 29.7.2026
SeekingAlpha · 29.7.2026
MT Newswires · 29.7.2026
Zacks · 29.7.2026
SeekingAlpha · 29.7.2026
ChartMill · 29.7.2026
Benzinga · 29.7.2026
SeekingAlpha · 26.7.2026
Stepan Company (SCL) currently has a StockIQ AI score of 53/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
SCL currently scores 53/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, SCL's estimated fair value is -$6.94, which is 111.0% below the current price of $62.87. This is one valuation model among several signals in the fair-value category, not a price target.
SCL's technical score is 72/100, which currently reads as bullish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Price is above the 50-day average; Price is above the 200-day average; RSI 54.9 — healthy positive momentum.
Based on the real signals StockIQ computed: Estimated fair value: -$6.94 vs. price $62.87 (-111.0%); Operating margin is eroding over time; Calmar: -0.13 (3y annualized return -7.5% / max drawdown 55.8%).
Yes — SCL has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Lisle Shawn G | Exercise of Derivative Securities | 26.8.2026 | 1,180 | +1,154 | $62.35 |
| Lisle Shawn G | Tax Withholding in Shares | 26.8.2026 | 841 | -339 | $62.35 |
| Lisle Shawn G | Exercise of Derivative Securities | 26.8.2026 | 2,308 | -1,154 | — |
| Lisle Shawn G | Exercise of Derivative Securities | 26.8.2026 | 1,154 | +1,154 | $62.35 |
| Lisle Shawn G | Tax Withholding in Shares | 26.8.2026 | 339 | -339 | $62.35 |
| Lisle Shawn G | Exercise of Derivative Securities | 26.8.2026 | 1,154 | -1,154 | — |
| Velasquez Ruben Dario | Exercise of Derivative Securities | 10.8.2026 | 1,358 | -1,358 | — |
| Velasquez Ruben Dario | Tax Withholding in Shares | 10.8.2026 | 398 | -398 | $64.68 |
| Velasquez Ruben Dario | Exercise of Derivative Securities | 10.8.2026 | 1,358 | +1,358 | $64.68 |
| Velasquez Ruben Dario | Exercise of Derivative Securities | 10.8.2026 | 1,394 | +1,358 | $64.68 |
| Velasquez Ruben Dario | Tax Withholding in Shares | 10.8.2026 | 996 | -398 | $64.68 |
| Velasquez Ruben Dario | Exercise of Derivative Securities | 10.8.2026 | 2,716 | -1,358 | — |
| Weitkamp Robin Joseph | Tax Withholding in Shares | 11.5.2026 | 50 | -50 | $52.58 |
| Weitkamp Robin Joseph | Exercise of Derivative Securities | 11.5.2026 | 90 | -90 | — |
| Weitkamp Robin Joseph | Exercise of Derivative Securities | 11.5.2026 | 90 | +90 | $52.58 |
| Weitkamp Robin Joseph | Exercise of Derivative Securities | 11.5.2026 | 90 | +90 | $52.58 |
| Weitkamp Robin Joseph | Tax Withholding in Shares | 11.5.2026 | 40 | -50 | $52.58 |
| Weitkamp Robin Joseph | Exercise of Derivative Securities | 11.5.2026 | 190 | -90 | — |
| Painter Corning F. | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
| STEPAN F QUINN JR | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
| Burgess Lorinda | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
| Dearth Randall S. | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
| REED JAN STERN | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
| Delgado Joaquin | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
| Lewis Susan | Grant/Award from Employer | 8.5.2026 | 2,566 | +2,566 | $52.61 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
689,825 shares short as of 2026-08-31 · vs. 591,427 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
74.0% of trading volume this week was short selling, vs. 69.9% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology